A practical reference on clinical endpoint: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-07-31 and is reviewed periodically as new material appears.
化学修饰延长了分子在体内的停留时间，使较低频次的给药安排成为可能。脂肪酸侧链通过与白蛋白结合延缓清除，非天然氨基酸则降低酶解速率。这些修饰同时改变分子的溶解性与稳定性，需要在制剂设计和储存条件中一并考虑。修饰引入的免疫原性风险也属于开发过程中需要评估的项目。
该化合物处于临床试验阶段，尚未在多数地区取得上市许可。公开信息主要来自企业公告、学术会议摘要与试验注册平台记录，完整数据仍在逐步披露。关于长期疗效与安全性的判断，需要等待规模更大、随访更久的研究结果，目前不宜对最终结论作出预判。
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
| Property | Value | Notes |
|---|---|---|
| 分子类别 | 合成多肽 | 含非天然氨基酸与脂肪酸侧链 |
| 分子量 | 约 4.7 kDa | 多肽量级，精确值随计法而异 |
| 外观 | 白色至类白色冻干粉 | 常见冻干形态，供复溶使用 |
| 溶解性 | 易溶于水 | 复溶后为澄清至微乳光液体 |
| 常见同义词 | LY3437943 | 开发阶段使用的代号 |
Quality control of research material relies on several complementary checks. Purity testing confirms the absence of truncated or oxidized peptide species, while water content and counterion analysis show how much mass comes from salts rather than the peptide itself. Sequence verification through tandem mass spectrometry ensures the correct amino acid chain. Because unregulated suppliers vary widely, independent verification of identity and purity is often necessary before a sample enters experiments.
Documentation plays a practical role in maintaining consistent results across laboratories. Certificates of analysis list purity, identity, and testing methods, and batch numbers allow comparisons between lots. Records of storage temperature and handling history help investigators interpret unexpected findings. When a sample behaves anomalously, reviewing that documentation often reveals whether the cause lies in the material or in the assay conditions.
Mechanistic proposals link each receptor to a different physiological role. Activation of the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors is associated with reduced appetite, slower gastric emptying, and glucose-dependent insulin release. Glucagon receptor signaling, by contrast, is associated with increased energy expenditure and altered lipid handling, though it can also raise blood glucose. The design intent is to balance these contributions so that weight reduction is enhanced without unacceptable glycemic trade-offs. How well that balance holds across individuals is not fully resolved.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
Randomized studies of retatrutide measure change in body weight as a percentage of baseline, along with absolute weight loss. Glycemic endpoints include hemoglobin A1c and fasting plasma glucose. Investigators also track blood pressure, lipid fractions, and liver fat content to characterize effects beyond weight alone. Trial designs typically use double-blind, placebo-controlled groups with periodic dose escalation, and they record adverse events throughout both treatment and follow-up periods.
Quantification of the peptide in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. This approach separates the analyte from matrix components and detects it by mass-to-charge transitions specific to the molecule. Immunoassays offer higher throughput but can cross-react with related peptides and metabolites, so mass spectrometric methods are preferred when structural confirmation is required. Method validation typically addresses accuracy, precision, selectivity, and stability under handling conditions.
=== Thioredoxin reductase === Thioredoxin reductase is also a key component of antioxidant defense. Although enzymes carrying out this function is found in most forms of life, the high-molecular-weight selenoprotein version found in animals evolved separately from the more common low-molecular-weight version. This version appears as a branch within the glutathione reductases, again a key component of antioxidant defense.
== Conventions == The three treaties are complementary and mutually supportive. They serve to maintain a classification system of controlled substances, including psychoactive drugs and plants, and chemical precursors, to ensure the regulated supply of those substances determined to be useful for medical and scientific purposes, and to otherwise prevent production, distribution and use, with some limited exceptions and exemptions. Adoption of the treaties is near universal among the UN's 193 member countries. The treaties are not self-executing, they operate indirectly by providing a skeleton template of provisions that have to be fleshed out in the domestic law of each member country. Thus each country has a degree of flexibility in conforming treaty obligations to their own socio-cultural, political and economic realities; this latitude has been described as a "vast grey area ... subject to judicial interpretation and political contestation." The cornerstone Single Convention on Narcotic Drugs (as amended in 1972) integrated into a single framework nine pre-existing international drug treaties dating back to 1912, and extended the control system, including to the cultivation of plants used for narcotic drugs. The subsequent two conventions addressed new developments and concerns; some 340 substances in total are listed across the three. For each of the conventions, an official Commentary provides comprehensive legal analysis to assist with interpretation.
For example, In 8th Harsh Environment Mass Spectrometry Workshop, a group of scientists presented their study about utilization of lightweight MS based instrumentation and small Unmanned Aerial Vehicles UAV platforms for in-situ volcanic plume analysis in Turrialba and Arenal volcanoes (Costa Rica). Mini mass spectrometers relying on miniature 18 mm rods transpector quadrupole for mTorr pressure operation, a miniature turbo molecular drag pump and assets like small, multi-parameter battery powered sensor suite MiniGas embedded with micro PC control system, and telemetry system were integrated in an aircraft to acquire 4D image of an erupting volcanic plume.
== Mechanism of action == Quinupristin and dalfopristin are protein synthesis inhibitors in a synergistic manner. While each of the two is only a bacteriostatic agent, the combination shows bactericidal activity.
==== Development of GLP-1-based therapies ==== During his tenure as chief scientific officer at Novo Nordisk, Thomsen played a significant role in the development of GLP-1-based therapies, including Ozempic and Wegovy. In the early 1990s, despite skepticism from company leadership regarding the potential of obesity treatments, Thomsen advocated for focusing on obesity as a significant health issue. This strategic direction led to the development of Ozempic, approved for Type 2 diabetes treatment in 2017, and Wegovy, approved for weight loss in 2021. Both medications are based on semaglutide, a GLP-1 receptor agonist designed to regulate blood sugar levels and appetite.
Sources: en.wikipedia.org
biotin) or clickable handles (azides or alkynes) enable enrichment of labeled enzymes prior to identification by liquid chromatography-tandem mass spectrometry (LC-MS/MS). After covalent labeling in cells or lysates, enzyme-probe adducts are captured using streptavidin or other affinity matrices, washed to remove unlabeled proteins, and digested for MS-based peptide identification. This strategy provides high sensitivity and depth of coverage, which facilitates the discovery of novel enzyme targets, detection of low-abundance enzymes and analysis of complex enzyme families. To compare enzyme activity across biological conditions, ABPP can be integrated with quantitative proteomic technologies to measure relative enzyme activity across samples. Techniques such as SILAC (Stable Isotope Labeling by Amino acids in Cell culture) incorporate heavy or light isotope-encoded amino acids into cellular proteins, facilitating direct MS-based comparison of probe-labeled peptides from different samples. TMT (Tandem mass tagging) which uses isobaric mass tags allows labeled peptides from multiple samples to be multiplexed and quantified simultaneously. These strategies have been widely applied to assess selectivity of covalent inhibitors and genome-wide changes in enzymatic activity. isoTOP-ABPP (Isotope Tagging of Optimized Probes for Activity-Based Protein Profiling) is a specialized workflow that was developed to address some of the limitations of conventional ABPP, including poor specificity, limited sensitivity, and the absence of selective chemical ligands for many human enzymes.
==== CIA assessment ==== At the latest, the successful start of Sputnik 2 with the satellite weighing more than 500 kg proved that the USSR had achieved a leading advantage in rocket technology. The CIA, initially astonished, estimated the launch weight of the rocket at 500 metric tons, requiring an initial thrust exceeding 1,000 tons, and assumed the use of a three-stage rocket. In a classified report, the agency described the event as a "stupendous scientific achievement" and concluded that the USSR had likely perfected an intercontinental ballistic missile (ICBM) capable of accurately targeting any location. In reality, the launch weight of the Soviet rocket was 267 metric tons with an initial thrust of 410 tons with one and a half stages. The CIA's misjudgement was caused by extrapolating the parameters of the US Atlas rocket developed at the same time (launch weight 82 tons, initial thrust 135 tons, maximum payload of 70 kg for low Earth orbit). In part, the favourable data of the Soviet launcher was based on concepts proposed by the German rocket scientists headed by Helmut Gröttrup on Gorodomlya Island, such as, among other things, the rigorous weight saving, the control of the residual fuel quantities and a reduced thrust to weight relation of 1.4 instead of usual factor 2. The CIA had heard about such details already in January 1954 when it interrogated Göttrup after his return from the USSR but did not take him seriously.
=== Ammonia solutions === The alkali metals dissolve slowly in liquid ammonia, forming ammoniacal solutions of solvated metal cation M+ and solvated electron e−, which react to form hydrogen gas and the alkali metal amide (MNH2, where M represents an alkali metal): this was first noted by Humphry Davy in 1809 and rediscovered by W. Weyl in 1864. The process may be speeded up by a catalyst. Similar solutions are formed by the heavy divalent alkaline earth metals calcium, strontium, barium, as well as the divalent lanthanides, europium and ytterbium. The amide salt is quite insoluble and readily precipitates out of solution, leaving intensely coloured ammonia solutions of the alkali metals. In 1907, Charles A. Kraus identified the colour as being due to the presence of solvated electrons, which contribute to the high electrical conductivity of these solutions. At low concentrations (below 3 M), the solution is dark blue and has ten times the conductivity of aqueous sodium chloride; at higher concentrations (above 3 M), the solution is copper-coloured and has approximately the conductivity of liquid metals like mercury. In addition to the alkali metal amide salt and solvated electrons, such ammonia solutions also contain the alkali metal cation (M+), the neutral alkali metal atom (M), diatomic alkali metal molecules (M2) and alkali metal anions (M−). These are unstable and eventually become the more thermodynamically stable alkali metal amide and hydrogen gas. Solvated electrons are powerful reducing agents and are often used in chemical synthesis.
== Diagnosis == Laboratory investigations usually show elevated creatine kinase, myopathic/dystrophic muscle pathology and altered α-dystroglycan. Antenatal diagnosis is possible in families with known mutations. Prenatal ultrasound may be helpful for diagnosis in families where the molecular defect is unknown.
As a second lieutenant in 1966, Noriega spent many months taking courses at the School of the Americas. The school was located at the United States Army's Fort Gulick in the Panama Canal Zone. Journalist John Dinges has suggested that Torrijos sent Noriega to the school to help him "shape up" and live up to Torrijos's expectations. Despite performing poorly in his classes, he was promoted to the rank of first lieutenant in 1966, and Torrijos found him a job as an intelligence officer in the "North Zone" of the National Guard. Shortly afterward, he returned to the School of the Americas for more training. At the school, Noriega participated in courses on infantry operations, counterintelligence, intelligence, and jungle warfare. He also took a course in psychological operations at Fort Bragg in North Carolina. Noriega's job required him to penetrate and disrupt the trade unions that had formed in the United Fruit Company's workforce, and he proved adept at this work. His new superior officer Boris Martínez was a fervent anti-communist, and enforced strict discipline on Noriega. Reports have suggested that he continued to pass intelligence to the U.S. during this period, about the plantation workers' activities. In 1967 the administration of U.S. President Lyndon B. Johnson concluded that Noriega would be a valuable asset, as he was a "rising star" in the Panamanian military. Later, as the de facto leader of Panama, Noriega maintained a close relationship with the School of the Americas, partly due to the school's presence in Panama.
Sources: en.wikipedia.org
指同一个分子能激活 GIP、GLP-1 和胰高血糖素三类受体。它与只激活一到两种受体的同类分子在设计思路上有所区别。这种设计的目的在于覆盖更多代谢调节通路。
天然肽类在体内容易被酶解并快速清除。脂肪酸侧链与非天然氨基酸可以延缓清除、降低酶解速率。修饰后的分子因此更适合较长间隔的给药安排。
公开资料主要来自临床阶段的报告与注册平台记录。这些材料提供的是阶段性信息，而非最终结论。完整的安全性与有效性数据仍在积累中。
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.